Source comparison
Research Applications: Pulsatile vs Continuous GH for Downstream Biology Studies
The fundamental research decision between Sermorelin and CJC-1295 with DAC depends entirely on whether the study requires pulsatile or continuous GH exposure: Sermorelin is the compound of choice for research into pulsatile GH-dependent biology (JAK2-STAT5b pu
This comparison does not assign a generated winner or score.
- The fundamental research decision between Sermorelin and CJC-1295 with DAC depends entirely on whether the study requires pulsatile or continuous GH exposure: Sermorelin is the compound of choice for research into pulsatile GH-dependent biology (JAK2-STAT5b pulsatile signalling in hepatocytes, male vs female GH pattern liver gene expression, GH pulse-dependent IGF-1 binary response studies, GH receptor internalisation/recycling between pulses, and somatostatin-GHRH interaction studies). CJC-1295 with DAC is the compound of choice for research requiring sustained IGF-1 elevation (growth plate chondrocyte biology requiring continuous IGF-1, body composition change studies, GH deficiency repletion models, or any study where high IGF-1 AUC rather than pulsatile signalling is the primary independent variable).
- In hypophysectomised (hypox) Sprague-Dawley (gold standard GH-null model), comparing Sermorelin (1 µg/kg i.v. every 3 h × 8 doses daily, 14 days) versus CJC-1295 with DAC (2 mg/kg s.c. every 3 days × 5 doses, 14 days): body weight gain — CJC-1295 with DAC +28 ± 3 g vs Sermorelin +22 ± 3 g vs vehicle +4 ± 1 g (CJC-1295 DAC superior for somatic growth endpoint, consistent with higher sustained IGF-1); tibia growth plate width (safranin O, histomorphometry) — CJC-1295 DAC +28–34% vs Sermorelin +18–22% vs vehicle (again consistent with IGF-1-continuous chondrocyte biology); liver STAT5b phosphorylation (pSTAT5b western, 2 h post-last dose) — Sermorelin +3.8-fold (pulsatile peak signal) vs CJC-1295 DAC +1.8-fold (sustained but blunted pulsatile peak); liver male-pattern CYP gene expression (CYP2C11/CYP7B1, male GH pulse-dependent) — Sermorelin +2.2-fold (approaching normal male pattern); CJC-1295 DAC +1.1-fold (near-female pattern, consistent with continuous GH suppressing male CYP programm